Weight loss, disease activity, and patient reported outcomes in patients with musculoskeletal and autoimmune diseases taking weight loss medications: a retrospective cohort study
Among participants with RMDs that reported weight loss medication use, ≥5 % weight loss was associated with statistically significant improvements in patient-reported disease activity and quality of life PROs. The use of weight loss medications could be considered in trials aimed at improving symptoms of RMDs.
Authors
- Katherine D. Wysham (ORCID: https://orcid.org/0000-0001-8707-7649)
- Kaleb D. Michaud (ORCID: https://orcid.org/0000-0002-5350-3934)
- Joshua F. Baker (ORCID: https://orcid.org/0000-0003-0799-7563)
- Michael George (ORCID: https://orcid.org/0000-0002-0398-2308)
- Kristin Wipfler (ORCID: https://orcid.org/0000-0001-8137-8117)
- Veena K. Ranganath
- Thomas R. Riley (ORCID: https://orcid.org/0009-0003-0194-7562)
Institutions
- University of California, Los Angeles (US)
- University of Washington (US)
- The National Databank for Rheumatic Diseases (US)
- Philadelphia VA Medical Center (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- Seminars in Arthritis and Rheumatism
- Published
- 2025-07-16
- DOI
- https://doi.org/10.1016/j.semarthrit.2025.152783
- Citations
- 1
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 1.67